CoDa Therapeutics Receives $19,200,000 Series B Funding Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=53296e7c-7b50-4a9f-b7d2-5f8a36cb8a86&Preview=1 -
Date
4/18/2011 -
Company Name
CoDa Therapeutics -
Mailing Address
10505 Sorrento Valley Road San Diego, CA 92121 -
Company Description
CoDa Therapeutics, Inc. is a San Diego-based pharmaceutical company focused on the development and commercialization of wound care therapeutics based on gap junction modulation. -
Website
http://www.codatherapeutics.com -
Transaction Type
Venture Equity -
Transaction Amount
$19,200,000 -
Transaction Round
Series B -
Proceeds Purposes
The financing will allow us to take essential steps for the development of CoDa; in particular, we will now conduct a large Phase 2 multicenter venous leg ulcer trial in the United States, New Zealand and Australia with Nexagon®, our lead product for chronic wound patients. In addition, we will continue the preclinical development of our product portfolio in our research laboratories. -
M&A Terms
-
Venture Investor
Domain Associates -
Venture Investor
GBS Venture Partners -
Venture Investor
Undisclosed
